We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Look to the Whole Body Effects of Drugs for Metastatic CNS Cancer, FDA Says
Look to the Whole Body Effects of Drugs for Metastatic CNS Cancer, FDA Says
Trials of drugs to treat cancer in the central nervous system (CNS) that has metastasized from solid tumors outside the CNS should examine whether the treatment controls the cancer at all disease sites, according to an FDA draft guidance released Wednesday.